<Record>
<Term>Ocrelizumab</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<ParentTerm>Monoclonal Antibody</ParentTerm>
<ClassificationPath>Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Pharmacologic Substance/Biological Agent/Monoclonal Antibody/Ocrelizumab,/NCIThesaurus/Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Pharmacologic Substance/Biological Response Modifier/Immunosuppressant/Ocrelizumab</ClassificationPath>
<BroaderTerm>Immunosuppressant</BroaderTerm>
<BroaderTerm>Ocrelizumab,</BroaderTerm>
<BroaderTerm>Chemicals_and_Drugs_Kind</BroaderTerm>
<BroaderTerm>Biological Agent</BroaderTerm>
<BroaderTerm>NCIThesaurus</BroaderTerm>
<BroaderTerm>Ocrelizumab</BroaderTerm>
<BroaderTerm>Pharmacologic Substance</BroaderTerm>
<BroaderTerm>Monoclonal Antibody</BroaderTerm>
<BroaderTerm>Biological Response Modifier</BroaderTerm>
<BroaderTerm>Drug, Food, Chemical or Biomedical Material</BroaderTerm>
<Synonym>OCRELIZUMAB</Synonym>
<Synonym>Ocrelizumab</Synonym>
<Source>NCI Thesaurus</Source>
</Record>
